Submitted by Anonymous (not verified) on 25 April 2025 - 13:38
Opinion/decision on a Paediatric investigation plan (PIP): Rydapt, Midostaurin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps);Oncology, PIP number: P/0068/2024
Source: